Recombinant Faricimab Biosimilar antibody
Quick Overview for Recombinant Faricimab Biosimilar antibody (ABIN7795163)
Target
Antibody Type
Reactivity
Host
Clonality
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Faricimab Biosimilar, Human ANGPT2/VEGFA Monoclonal Antibody
-
Characteristics
- The anti-human ANGPT2/VEGFA monoclonal antibody faricimab biosimilar was produced in mammalian cells.
-
Purification
- Protein A or G affinity column
-
Purity
- >95 % by reducing SDS-PAGE
-
Endotoxin Level
- < 1 EU per 1 mg of the protein by the LAL method
-
Isotype
- IgG1, kappa, lambda
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- > 3 mg/mL
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- Faricimab Biosimilar
-
Target Type
- Biosimilar
Target
-